149 related articles for article (PubMed ID: 29881288)
1. High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer.
Zhang M; Li X; Fan Z; Zhao J; Liu S; Zhang M; Li H; Goscinski MA; Fan H; Suo Z
Onco Targets Ther; 2018; 11():3149-3157. PubMed ID: 29881288
[TBL] [Abstract][Full Text] [Related]
2. Increased Sushi repeat-containing protein X-linked 2 is associated with progression of colorectal cancer.
Liu KL; Wu J; Zhou Y; Fan JH
Med Oncol; 2015 Apr; 32(4):99. PubMed ID: 25737434
[TBL] [Abstract][Full Text] [Related]
3. Impact of overexpression of Sushi repeat-containing protein X-linked 2 gene on outcomes of gastric cancer.
Yamada T; Oshima T; Yoshihara K; Sato T; Nozaki A; Shiozawa M; Ota M; Yoshikawa T; Akaike M; Numata K; Rino Y; Kunisaki C; Tanaka K; Imada T; Masuda M
J Surg Oncol; 2014 Jun; 109(8):836-40. PubMed ID: 24700475
[TBL] [Abstract][Full Text] [Related]
4. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer.
Li S; Yin L; Huang K; Zhao Y; Zhang H; Cai C; Xu Y; Huang L; Wang X; Lan T; Li H; Ma P
J Cancer; 2019; 10(7):1755-1763. PubMed ID: 31205531
[No Abstract] [Full Text] [Related]
7. RRBP1 is highly expressed in prostate cancer and correlates with prognosis.
Li T; Wang Q; Hong X; Li H; Yang K; Li J; Lei B
Cancer Manag Res; 2019; 11():3021-3027. PubMed ID: 31118771
[No Abstract] [Full Text] [Related]
8. MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer.
Li X; Ji Y; Han G; Li X; Fan Z; Li Y; Zhong Y; Cao J; Zhao J; Zhang M; Wen J; Goscinski MA; Nesland JM; Suo Z
BMC Cancer; 2016 Nov; 16(1):894. PubMed ID: 27852261
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of SRPX2 inhibits the proliferation, migration, and invasion of prostate cancer cells through the PI3K/Akt/mTOR signaling pathway.
Hong X; Hong X; Zhao H; He C
J Biochem Mol Toxicol; 2018 Dec; ():e22237. PubMed ID: 30537353
[TBL] [Abstract][Full Text] [Related]
10. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.
Sasahira T; Kurihara-Shimomura M; Nishiguchi Y; Shimomura H; Kirita T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455867
[TBL] [Abstract][Full Text] [Related]
11. SRPX2 Enhances the Epithelial-Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells.
Tang H; Zhao J; Zhang L; Zhao J; Zhuang Y; Liang P
Cell Mol Neurobiol; 2016 Oct; 36(7):1067-76. PubMed ID: 26643178
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
13. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma.
Lin X; Chang W; Wang Y; Tian M; Yu Z
Biomed Pharmacother; 2017 Sep; 93():398-405. PubMed ID: 28654796
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of tumor protein D54 is associated with clinical progression and poor prognosis in patients with prostate cancer.
Ren L; Chen J; Zhang X
Oncol Lett; 2017 Dec; 14(6):7739-7744. PubMed ID: 29250174
[TBL] [Abstract][Full Text] [Related]
15. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer.
Wu W; Bai S; Zhu D; Li K; Dong W; He W; Peng S; Lai Y; Wang Q; Guo Z; Liu L; Huang H
Oncol Lett; 2019 May; 17(5):4640-4646. PubMed ID: 30944653
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
18. Expression of SOCSs in human prostate cancer and their association in prognosis.
Zhu JG; Dai QS; Han ZD; He HC; Mo RJ; Chen G; Chen YF; Wu YD; Yang SB; Jiang FN; Chen WH; Sun ZL; Zhong WD
Mol Cell Biochem; 2013 Sep; 381(1-2):51-9. PubMed ID: 23666742
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of shugoshin1 predicts a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Mu J; Fan L; Liu D; Zhu D
Onco Targets Ther; 2019; 12():1111-1118. PubMed ID: 30799941
[TBL] [Abstract][Full Text] [Related]
20. SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion.
Tanaka K; Arao T; Maegawa M; Matsumoto K; Kaneda H; Kudo K; Fujita Y; Yokote H; Yanagihara K; Yamada Y; Okamoto I; Nakagawa K; Nishio K
Int J Cancer; 2009 Mar; 124(5):1072-80. PubMed ID: 19065654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
